NPFCX
Price
$60.62
Change
+$0.36 (+0.60%)
Updated
Jan 23 closing price
Net Assets
147.67B
RNGBX
Price
$55.79
Change
+$0.24 (+0.43%)
Updated
Jan 23 closing price
Net Assets
37.76B
Ad is loading...

NPFCX vs RNGBX

Header iconNPFCX vs RNGBX Comparison
Open Charts NPFCX vs RNGBXBanner chart's image
American Funds New Perspective C
Price$60.62
Change+$0.36 (+0.60%)
VolumeN/A
Net Assets147.67B
American Funds New Economy R2
Price$55.79
Change+$0.24 (+0.43%)
VolumeN/A
Net Assets37.76B
NPFCX vs RNGBX Comparison Chart
Loading...
View a ticker or compare two or three
VS
NPFCX vs. RNGBX commentary
Jan 24, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NPFCX is a StrongBuy and RNGBX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
NPFCX has more cash in the bank: 148B vs. RNGBX (37.8B). NPFCX pays higher dividends than RNGBX: NPFCX (0.20) vs RNGBX (0.00). NPFCX was incepted earlier than RNGBX: NPFCX (24 years) vs RNGBX (23 years). RNGBX is a more actively managed with annual turnover of: 39.00 vs. NPFCX (17.00). NPFCX (250) and RNGBX (250) have matching initial minimum investment requirements. NPFCX (15.26) and RNGBX (14.99) have marching annual gain over last year. NPFCX return over 5 years is better than : 30.44 vs. RNGBX (28.74).
NPFCXRNGBXNPFCX / RNGBX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence24 years23 years-
Gain YTD4.0765.70971%
Front LoadN/AN/A-
Min. Initial Investment250250100%
Min. Initial Investment IRAN/AN/A-
Net Assets148B37.8B392%
Annual Yield % from dividends0.200.00-
Returns for 1 year15.2614.99102%
Returns for 3 years5.8416.8235%
Returns for 5 years30.4428.74106%
Returns for 10 years69.4055.04126%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
HTCR1.690.07
+4.32%
Heartcore Enterprises
PEBO32.200.85
+2.71%
Peoples Bancorp
CLVT5.440.08
+1.49%
Clarivate Plc
CRDF3.540.02
+0.57%
Cardiff Oncology
CQP60.51-2.28
-3.63%
Cheniere Energy Partners LP